IPM and the Council aim to ensure a sustainable future for the ring program and expand women’s prevention choices
The Population Council, a global nonprofit research organization and developer of sexual and reproductive health pharmaceuticals, and the International Partnership for Microbicides (IPM), a nonprofit organization that develops HIV prevention technologies for women, are pleased to announce that they have signed an agreement for the Population Council to acquire IPM’s dapivirine vaginal ring pipeline and other assets. The organizations will work toward completing the transaction over the next two months, ensuring that all projects continue uninterrupted. Additional details will be announced when the process is complete.
During its 158th meeting held on 27–28 June, the Population Council’s Board of Trustees strengthened and demonstrated accountability to its commitment to Board diversity by approving revisions to its diversity statement which was adopted in June 2021. Notably, the revised statement includes goals on Board composition in relation to gender and representation from low- and middle-income countries and early/mid-career individuals.
The United Nations estimates the world's population will hit eight billion this year.
Population issues are among the most critical challenges the world faces in the 21st century.
The US Supreme Court's vote to abolish the right to abortion is a decision that global health advocates fear will have worldwide implications. The biggest concern is that US lawmakers might now make use of a "global gag rule" which gives them the right to block all federal funding to non-US organisations that provide abortion services or information.
The Population Council pays tribute to Dr. Ian Stewart Fraser and his contributions to ensuring the sexual and reproductive health, rights, and choices of populations around the world. Fraser passed away on 28 June.